New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 9, 2012
09:08 EDTCBPOChina Biologic gaps up sharply, levels to watch
The shares are up over 17.5% in the pre-market. Resistance is at $13.29. Support is at $11.96.
News For CBPO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 2, 2015
08:35 EDTCBPOChina Biologic enters into collaboration agreement to source raw materials
China Biologic announced that the company's subsidiary Guizhou Taibang Biological Products entered into a strategic collaboration agreement with Xinjiang Deyuan Bioengineering to source raw plasma. The Agreement allows Guizhou Taibang to source no less than 500 tonnes of source plasma from Xinjiang Deyuan over the next three years. The raw plasma will be shipped in batches to Guizhou Taibang for the production of human albumin and IVIG products. The company expects that the products made from the sourced raw plasma will begin to reach the market in second half of 2016. As required and approved by the local regulator, during the term of the Agreement, Xinjiang Deyuan will entrust the operation of its plasma collection stations to Guizhou Taibang. As part of the Agreement, Guizhou Taibang agreed to lend to Xinjiang Deyuan an interest-bearing loan with a principal amount of approximately $47M). The loan is due July 31, 2018 and is secured by a pledge of a 58.02% equity interest in Xinjiang Deyuan from its controlling shareholder. The loan to Xinjiang Deyuan and the raw plasma will be funded primarily by the Company's cash released from a collateral deposit to secure a USD-denominated loan that the Company repaid in full in June 2015.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use